Celebrating Kim Russell’s 20 Years of Service to Texas Retina
As we continue to recognize team members who have been a part of the Texas Retina family for 20+ years, this week we are celebrating Kim Russell. She joined our practice in
read more
New Clinical Trials at Texas Retina
Over the past two decades, Texas Retina physicians have participated in more than 100 national clinical trials, offering our patients access to promising new treatments for a variety of retina conditions, including
read more
Our Offices Will Close for Memorial Day
All Texas Retina Associates offices will be closed on Monday, May 27, in observance of Memorial Day. We remember and honor all who gave their lives in service to our country.
read more
Dr. Abbey Presented Key Results of DAVIO 2 Clinical Trial for Wet AMD at Retina World Congress
At the recently held 2024 Retina World Congress Meeting, Texas Retina’s Dallas Director of Clinical Research Ashkan M. Abbey, MD, presented topline results from the DAVIO 2 clinical trial investigating EYP-1901 (Duravyu),
read more
Celebrating Rita Vega’s 21+ Years of Service to Texas Retina
We continue to recognize Texas Retina team members who have served our practice for 20 years or more. Today, we honor Rita Vegas, who joined Texas Retina in 2002 and currently serves
read more
May is Ocular Melanoma Awareness Month
Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina, we have been caring for ocular melanoma
read more Dr. Abbey Presents GALE Study Data at the Association for Research in Vision and Ophthalmology
At this year’s ARVO 2024, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), Texas Retina’s Dr. Abbey presented 36-month data from the GALE study of pegcetacoplan (brand
read more
Texas Retina Associates Participating in Phase III Clinical Trial for Choroidal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina is now participating in the Phase III AU-011 clinical trial (CoMpass) for treatment of small choroidal (ocular) melanoma. Together with Aura
read more
May is Healthy Vision Month: Take These 10 Steps to Protect Your Eyes
The National Eye Institute has designated May as Healthy Vision Month. It is the perfect time to learn how to protect your eyes and vision, and to encourage your family members to
read more
Texas Retina Recognizes Debbie Krahl for 23 Years of Service
As we continue to celebrate our team members who have served Texas Retina for 20+ years, today we recognize Debbie Krahl, who currently serves as a Clinical Site Coordinator and Scribe in
read more